law.com
22-May-2008
Pharmaceutical companies eager to keep less expensive alternatives to their drugs off the market are increasingly reaching legal agreements with generic drugmakers to accomplish that goal, a government agency said Wednesday. The FTC says that by jamming the pipeline of cheaper drugs, such...
[read full story]